MUC1 and breast carcinoma: In accordance with increased cross-presentation and activation of cytotoxic T cells by mannosylated SLPs observed here, targeting of the breast cancer mucin MUC1 towards the MR resulted in enhanced cross-presentation, an increased CD8+ T cell cytotoxicity and a reduced humoral response.